ImmuneSpec Revenue

Biotechnology Research • Niel, Flemish Region, Belgium • 11-20 Employees

ImmuneSpec revenue & valuation

Annual revenue	$1,197,770
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,900,000
Total funding	No funding

Key Contacts at ImmuneSpec

Ellen Boelen

Director Business Development

Elise Pepermans

Ceo & Co-Founder

Kurt Boonen

Chief Data Officer - Co-Founder

Company overview

Headquarters	Galileilaan 18, Niel, Flemish Region 2845, BE
Phone number	+32797707610
Website	immunespec.com
NAICS	541714
Keywords	Immunology, Lc-Ms/Ms, Immunopeptidomics, Mapps, Mhc-Associated Peptide Proteomics, Neoantigen Discovery, Antigen Discovery, Antigen Presentation Validation, Ligandomics, Peptide Vaccine Development
Founded	2023
Employees	11-20
Socials

ImmuneSpec Email Formats

ImmuneSpec uses 3 email formats. The most common is {first initial} (e.g., j@immunespec.com), used 33.3% of the time.

Format	Example	Percentage
{first initial}	j@immunespec.com	33.3%
{first initial}.{last name}	j.doe@immunespec.com	33.3%
{first name}.{last name}	john.doe@immunespec.com	33.3%

About ImmuneSpec

ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentation—enabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapies—from personalized medicine to next-generation vaccines and immunotherapies.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

ImmuneSpec has 10 employees across 7 departments.

Departments

Number of employees

Funding Data

ImmuneSpec has never raised funding before.

ImmuneSpec Tech Stack

Discover the technologies and tools that power ImmuneSpec's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

HTTP/3

Miscellaneous

HSTS

Security

Microsoft 365

Frequently asked questions

ImmuneSpec is located in Niel, Flemish Region, BE.

You can reach ImmuneSpec at +32797707610.

ImmuneSpec generates an estimated annual revenue of $1,197,770. This revenue figure reflects the company's market position and business performance in its industry.

ImmuneSpec has an estimated valuation of $3,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ImmuneSpec was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

ImmuneSpec has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.